NASDAQ:MRKR   Marker Therapeutics, Inc
Marker Therapeutics , Inc. , a clinical stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications.